Waldencast closes Obagi sale as core loss widens
What happened Waldencast plc (NASDAQ: WALD) said on September 28, 2026 that it completed the sale of Obagi Medical to Bridgepoint on July 30, 2026. The company said Obagi met held-for-sale criteria and that the sale was a strategic shift with a major effect on operations and financial results. For the first half of 2026, […]
28 Sep 23:02 · The Markets Daily